Interferon alpha (IFN-a) therapy is associated with a number of immunological side-effects, including autoimmune diseases and a 10% prevalence of thyroiditis. Hepatitis C virus (HCV ) infection itself predisposes to autoimmune phenomena including hypothyroidism and myositis. The development of clinical hypothyroidism in the presence of positive thyroid antibodies in patients infected with HCV and treated with IFN-a suggests a possible association between the viral disease and the therapy. HCV infection may predispose to autoimmune thyroid disease and IFN-a therapy may secondarily lead to the development of thyroid dysfunctions. We report the single case of a female patient who developed a severe proximal myopathy in conjunction with primary hypothyroidism (Hoffmann's syndrome) secondarily to IFN-a therapy for HCV infection. This case highlights the need for careful clinical and biological monitoring for potential side-effects in such patients. Laboratory tests showed a normal white blood cell count <41]. Ten years previously, she suffered from jaundice which and erythrocyte sedimentation rate. The C-reactive protein was attributed to HCV infection, although there was no was <6 mg/l (normal: <10), and renal function tests were serological proof for this. Further investigations included normal. Liver function tests revealed a high SGOT of 96 virological tests which confirmed the diagnosis of active HCV [normal range (NR) 9-32 IU/l ] and a normal SGPT. Serum infection (positive HCV RNA in serum and anti-HCV muscle enzymes revealed an increased level of creatine phosantibody) and a liver biopsy which revealed chronic aggresphokinase (CPK ) of 2398 IU/l (NR 25-140), increased sive hepatitis with moderate lobular destruction and periportal aldolase of 11.5 (normal: <7.8). Immunological investilymphoid follicles. Autoantibody screen [antinuclear antibodgations showed the absence of ANA and anti-DNA antibodies, normal C3 and C4 levels, and the presence of antiperoxidase antibodies ( TPO-Ab) of 340 kU/l (normal:
CASE HISTORY indurated and tender over both forearms and lower legs. Muscle strength was diminished in the proximal and distal In November 1995, a 33-yr-old housewife developed right muscle groups of the upper limbs, but well preserved in the upper quadrant abdominal pain associated with liver function lower limbs. Tendon reflexes were slightly prolonged. test abnormalities [aspartate aminotransferase (SGOT ) 69 IU/l, alanine aminotransferase (SGPT ) 123 IU/l, normal:
Laboratory tests showed a normal white blood cell count <41]. Ten years previously, she suffered from jaundice which and erythrocyte sedimentation rate. The C-reactive protein was attributed to HCV infection, although there was no was <6 mg/l (normal: <10), and renal function tests were serological proof for this. ute to the clinical manifestations. We were unable to Because of a suspicion of possible scleroderma, a skin biopsy find any other report of a similar complication relating of the distal forearm was performed which showed slight to IFN-a treatment.
non-specific inflammation of the dermis without fibrosis.
Thyroid dysfunctions are commonly reported with
Immunofluorescence examination was negative.
IFN-a treatment. In HCV-infected patients, one study ulatory effects. They may influence humoral mechanisms of immunity by stimulating the production of DISCUSSION antibodies mediated through T-helper cell activation Our patient developed a severe hypothyroid myoand, possibly, through T-suppressive cell inhibition. pathy in association with INF-a therapy, which clinicEffects on cellular immune mechanisms include natural ally fits the description of Hoffmann's syndrome, an killer cell activation, increased membrane expression unusual complication of myxoedema [4] . Although of MHC antigens and enhanced antibody-dependent musculoskeletal symptoms are common in hypothyroid lymphocyte cytotoxicity [1] . patients, affecting as many as 50%, in Hoffmann's Two theories have been proposed to explain the syndrome there is myopathy with pseudohypertrophy occurrence of immunological disorders with INF-a of distal muscle groups, due to increased amounts of treatment. Firstly, a direct toxicity of INF-a on particuconnective tissue and mucopolysaccharide deposits in lar organs and, secondly, a possible exacerbation of a muscles. In our patient, there was a marked elevation silent pre-existing autoimmune disease by the INF-a. of CPK and aldolase, indicating muscle involvement.
Another possible pathogenetic mechanism is autoAn MRI scan was performed due to an initial suspicion of fasciitis, which revealed gadolinium enhancement of immunity induced by HCV infection itself. Apart from the perimysial and intermuscular fascia, compatible the well-known association between chronic HCV with fasciitis. To our knowledge, this is the first report infection and mixed essential cryoglobulinaemia, HCV infection has also been reported in association with rheumatoid arthritis [2] , Sjö gren's syndrome [6, 7] and inflammatory myositis [3] . HCV infection per se may also increase the risk of developing thyroid autoimmunity. Preziati et al. [8] reported that of 78 HCV-infected patients who received IFN-a, 35.9% had increased anti-peroxidase antibodies and 16.7% increased levels of anti-thyroglobulin antibodies before treatment started. Of 35 patients who remained on treatment at 12 months, 11 had developed thyroid disorders: seven had primary hypothyroidism, one had transient hypothyroidism and three hyperthyroidism. Among these 11 patients, eight had elevated basal anti-TPO and/or anti-thyroglobulin ( TG) antibody levels that increased during therapy. We assayed for the presence of these antibodies retrospectively in our patient, and she was found to have elevated levels of both anti-TPO and anti-TG antibodies before starting therapy (1405 and 123 KU/l, respectively, normal: <100 kU/l ). We therefore postulate that HCV infection by itself predisposes to thyroid autoimmunity, which in our patient was silent before treatment started, but which became symptomatic during her therapy. No studies to date allow us to say whether this form of 'exacerbated autoimmunity' is limited to thyroid diseases, or whether it extends to include other auto- earlier.
